相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The perinatal implications of angiogenic factors
Gordon C. S. Smith et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
Severe intrauterine growth restriction pregnancies have increased placental endoglin levels - Hypoxic regulation via transforming growth factor-beta 3
Yoav Yinon et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Preeclampsia and angiogenic imbalance
Sharon Maynard et al.
ANNUAL REVIEW OF MEDICINE (2008)
Weight at birth and all-cause mortality in adulthood
Jennifer L. Baker et al.
EPIDEMIOLOGY (2008)
Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry
Abdalla E. Diab et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2008)
Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction
Ori Nevo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age
Offer Erez et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
Roberto Romero et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Molecular mechanisms of preeclampsia
Walter P. Mutter et al.
MICROVASCULAR RESEARCH (2008)
Maternal serum placental growth factor (PIGF) in small for gestational age pregnancy at 11+0 to 13+6 weeks of gestation
Leona C. Y. Poon et al.
PRENATAL DIAGNOSIS (2008)
The fetal response to chronic placental insufficiency
Mark G. Neerhof et al.
SEMINARS IN PERINATOLOGY (2008)
Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
Holger Stepan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth
Gordon C. S. Smith et al.
OBSTETRICS AND GYNECOLOGY (2007)
Changes in circulating level of angiogenic factors from first to second trimester as predictors of preeclampsia
Lars J. Vatten et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction
Wenzel Wallner et al.
CLINICAL SCIENCE (2007)
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction
Makrina D. Savvidou et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction
Fatima Crispi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates
Theodora Boutsikou et al.
EARLY HUMAN DEVELOPMENT (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation
KA Wathen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: Relationship to circulating placental growth factor
E Shibata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia
R Thadhani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Developmental plasticity and human health
P Bateson et al.
NATURE (2004)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia
SE Maynard et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences
V Tsatsaris et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies
RN Taylor et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Vascular endothelial growth factor Ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe Preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome
Y Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Birthweight by gestational age in Norway
R Skjærven et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2000)
分享论文
